European Union: Solvency II: Finally Final

The European Council has approved the Omnibus II Directive ("O2"). With the adoption of O2, the Solvency II framework Directive (2009/138/EC, "S2") is finally final. This does not mean that all is clear. Further details concerning many subjects still need to be provided in delegated and implementing acts and in guidelines. Yet, we now finally have the definitive text of the framework directive. The text of O2 is expected to be published in May 2014.

This legal alert highlights the main changes that O2 makes to S2. Insurers should take these changes into account when preparing for the implementation of S2 as of 1 January 2016. Though we only refer to the position of insurers in this legal alert, the points we address will similarly apply to reinsurers.

We discuss the impact of the Lisbon Treaty and European System of Financial Supervision, the long-term guarantee package, third country equivalence, the transitional measures, and phasing-in of S2. We also note a few other changes that have less of an impact.


During the negotiations on O2, the main focus of the insurance sector shifted to the treatment of long-term guarantees under S2 (see 2. Long-term guarantee package). This makes it easy to forget that the main initial purpose of O2 was to align S2 with the Lisbon Treaty and with the European System of Financial Supervision ("ESFS") introduced in 2010.

The Lisbon Treaty replaced the European "comitology" procedure for adoption of technical implementing measures by a system of "delegated acts" and "implementing acts" to be adopted by the European Commission. O2 makes the necessary changes in S2 to accommodate this new system.

Under the ESFS, the European Insurance and Occupational Pensions Authority ("EIOPA") has a larger role to play than under the former system. S2 did not provide for the necessary basis for EIOPA to fulfil its tasks as envisaged under the ESFS and set out in its founding regulation (Regulation (EU) 1094/2010). This is introduced by O2.

Roles of EIOPA

EIOPA fulfils many roles under the ESFS which are set out in its founding regulation. We note the following roles, most of which have been impacted by O2:

Advisory role (not impacted by O2)

  • EIOPA advises European institutions on issues related to its area of competence. EIOPA for instance advised the European Commission on S2 and the delegated acts further detailing S2.

Regulatory role

  • O2 sets out the specific areas in which EIOPA has the power to develop draft regulatory and implementing technical standards for adoption by the European Commission by means of delegated or implementing acts. This new role of EIOPA means that insurers need to engage in consultations held by EIOPA to be able to influence the outcome of important rules applicable to insurers. EIOPA is currently in the process of publicly consulting its first set of implementing technical standards under S2. The consultation ends 30 June 2014. It follows from the "sunrise provision" that for two years after O2 comes into force, EIOPA has no role to play when the European Commission adopts regulatory technical standards. The sun will shine for EIOPA after that initial period of two years or if any amendment is made to such delegated act before then.
  • EIOPA has the power to issue level 3 guidelines to further supervisory convergence, for instance with respect to the S2 implementation (not impacted by O2). Also here, participation in the consultations held by EIOPA when drafting these guidelines is important.

Supervisory role

  • O2 sets out specific areas in which EIOPA has binding mediation power if supervisory authorities from different member states disagree. EIOPA first acts as mediator, but is able to settle the matter if the conciliation attempt does not result in agreement. Examples of areas in which EIOPA has these mediation powers are the decision whether to grant permission for a group internal model and the decision to designate a different group supervisor than follows from the standard criteria.
  • O2 clarifies that EIOPA is a member of the colleges of supervisors for insurance group supervision. EIOPA's specific tasks with respect to these colleges are set out in its founding regulation.
  • EIOPA supervises the national supervisory authorities and has a role to play in case of breach or non-application of EU law (not impacted by O2).
  • In specific situations EIOPA may adopt an individual decision addressed to an insurer requiring the necessary action to comply with its obligations under EU law (not impacted by O2).

Other roles

  • O2 requires that EIOPA publish certain technical information, for instance for the calculation of the best estimate (technical provisions), the matching adjustment and the volatility adjustment (see 2. Long-term guarantee package). The European Commission may adopt implementing acts setting out this technical information, which then obligates insurers to use this technical information in making the relevant calculations.
  • S2 allowed supervisory authorities to extend the recovery period for insurers not meeting their solvency capital requirement with an appropriate period of time "in the event of an exceptional fall in financial markets". O2 provides that this extension can only be given if EIOPA has declared an "exceptional adverse situation". O2 and the draft Delegated Acts dated 14 March 2014 ("draft Delegated Acts S2") contain further details on when an exceptional adverse situation exists and what factors are to be taken into account to determine the length of the extension. The maximum extension period is seven years. Outside of an exceptional adverse situation, the recovery period is six months with a possible extension of three months (not impacted by O2).
  • O2 requires EIOPA to report on the impact of the long-term guarantee measures (see 2. Long-term guarantee package), the measures on equity risk (the duration-based equity risk sub-module and symmetric adjustment mechanism; not impacted by O2) and the measures with respect to exceptional adverse situations. Ultimately EIOPA must submit an opinion to the European Commission on the assessment of the application of these measures, which the Commission will use for its report to the European Parliament and Council by 1 January 2021 at the latest, if necessary accompanied by legislative proposals.


Concerns regarding long-term guarantees had held up the negotiations on O2 for a long time. What were the discussions all about?

Long-term guarantees are part of products such as annuities. They pay fixed amounts over a defined period of time in the future. When calculating the best estimate (technical provisions), insurance obligations in principle are discounted using the relevant risk-free interest rate term structure to be published by EIOPA. It follows from the draft Delegated Acts S2 that the basic risk-free interest rates are derived on the basis of interest rate swap rates for interest rates of each currency, adjusted for credit risk. O2 describes the high level principles for extrapolation of the risk-free interest rate term structure for maturities where the markets for the relevant financial instruments or for bonds are no longer "deep, liquid and transparent". Further detail is provided in the recitals of O2 and in the draft Delegated Acts S2.

The discounted best estimate is higher if the discount rate is lower. Insurers have argued that with respect to long-term guarantees they should be allowed to use a higher discount rate (i.e., add a premium to the risk-free rate). Their reasoning is that they can match the long-term guarantees with assets that have long maturity dates. As they aim to hold these assets to maturity, they do not run any risks with respect to these assets other than outright default. In other words: insurers reason that they do not run all the risks with respect to those assets that other investors do. Therefore, the part of the spread on that asset that does not correspond with the "fundamental spread" (corresponding to default risk) should be added to the risk-free interest rate term structure. This is exactly what the "matching adjustment", introduced by O2, does, although it also includes the risk of a downgrade in the fundamental spread. If an insurer were not allowed to make this adjustment, there would be artificial volatility in its own funds. This would be the result of the value of its assets (bonds) going down if the spread, other than the fundamental spread, for those bonds goes up while the value of its technical provisions (the largest part of the liabilities of an insurer) would not be reduced. This results in lower own funds (in short, assets minus liabilities) while the reduced value of the assets will not be realised. Of course, the opposite applies if the spread goes down.

A flanking measure is the volatility adjustment. This adjustment is aimed at preventing pro-cyclical investment behaviour. The long-term guarantee package is completed by transitional measures with respect to the risk-free interest rate structure and the technical provisions.

Although O2 technically does not limit the use of the long-term guarantee measures to long-term guarantees, they will have the greatest use with respect to these obligations. This is because a change in a discount rate has a bigger effect when discounting takes place over a longer period.

Matching adjustment

The matching adjustment allows an insurer, subject to approval from the relevant supervisory authority, to apply a premium to the relevant risk-free interest rate term structure to calculate the best estimate. As a maximum the matching adjustment is 70% of the spread on (in short) EEA sovereign debt and 65% of the spread on other debt. It follows from the draft Delegated Acts S2 that extrapolation must be based on the risk-free interest rates without a matching adjustment. The matching adjustment must be applied to the extrapolated risk-free interest rates.

The matching adjustment may only be used if certain strict conditions are met. Most importantly:

  • only bonds and other assets with similar cash-flow characteristics can be assigned to cover the best estimate of the portfolio of the insurance obligations
  • the assignment of assets in principle must be maintained over the lifetime of the obligations;
  • the obligations and the assets must be identified, organised and managed separately from other activities of the insurer and the assigned assets cannot be used to cover losses arising from other activities (but no formal ring-fencing requirement applies)
  • the cash flows of the assets and obligations must be matched and in principle the cash flows of the assigned assets must be fixed
  • the contracts underlying the insurance obligations may not give rise to future premium payments and they may not include options for the policy holders, other than a surrender option where the surrender value does not exceed the assigned assets
  • the only underwriting risks connected to the insurance obligations may be longevity risk, expense risk, revision risk and mortality risk.

There is no requirement to substitute assets if they no longer have a certain credit quality, as was the case in previous thinking on the matching adjustment. We therefore wonder whether the risk of a downgrade should still be seen as a separate risk that an insurer runs with respect to its long-term guarantees and whether it should therefore be part of the fundamental spread (see the introduction to this section).

The matching adjustment cannot be used in conjunction with the volatility adjustment or the transitional measure with respect to the risk-free interest rate structure. It is unclear whether the matching adjustment can be used in combination with the transitional measure with respect to the technical provisions.

Volatility adjustment

The volatility adjustment allows insurers to increase the relevant risk-free interest rate term structure for the calculation of the best estimate by 65% of the portion of the spread of a reference portfolio that is not attributed to "a realistic assessment of expected losses or unexpected credit or other risk of the assets". It follows from the draft Delegated Acts S2 that this – as with the matching adjustment – comes down to (65% of) the spread minus the fundamental spread. There is also an additional allowance for a risk-corrected country spread. The volatility adjustment applies only to the risk-free interest rates of the term structure that are not derived by means of extrapolation and the extrapolation of the term structure must be applied on those risk-free interest rates including the volatility adjustment.

As follows from its name, there is no requirement for the insurer to hold the assets in the reference portfolio, as is the case with respect to the matching adjustment. However, to the extent the assets actually held by the insurer differ from the assets in the reference portfolio, the effectiveness of the volatility adjustment will diminish.

The requirements to be met by the reference portfolio are set out in the draft Delegated Acts S2. We note that the reference portfolio may consist of bonds, securitisations, loans, equity and property, that the assets must be representative of the investments made by insurers (it seems, in general) to cover the best estimate and that, where available, the portfolio must be based on relevant indices. Member states may require prior approval by supervisory authorities for insurers to apply a volatility adjustment.

The volatility adjustment cannot be combined with the matching adjustment. The interplay between the volatility adjustment and the transitional measure with respect to the risk-free interest rate structure is complicated, but effectively comes down to the transitional measure taking precedence, while the calculation is based on the volatility adjusted risk-free interest rate. The calculation under the transitional measure with respect to the technical provisions is based on the volatility adjusted risk-free interest rate, but it seems that the volatility adjustment can also be used in conjunction with the transitional measure.

Transitional measures

The transitional measure with respect to the risk-free interest rate term structure allow insurers for insurance obligations existing on 31 December 2015, subject to prior approval by the supervisory authority, to phase into the S2 term structure over a period of 16 years. As many Dutch insurers use the DNB published risk-free interest rate term structure, we do not expect this transitional measure to be of much significance for them.

The transitional measure with respect to the technical provisions allow insurers, subject to prior approval by the supervisory authority, to phase into the S2 calculation of the technical provisions over a period of 16 years. The transitional measure seems to effectively only relate to insurance obligations existing on 31 December 2015.

These transitional measures may not be combined. See the sub-sections Matching adjustment and Volatility adjustment for the possibility of combining the transitional measures with the matching adjustment or the volatility adjustment.

An insurer that applies either transitional measure and observes that it would not meet the solvency capital requirement without application of that transitional measure must inform the supervisory authority as soon as possible. In a phasing-in plan, the insurer should set out the measures planned to ensure compliance at the end of the transitional period.

Consequences of using the long-term guarantee measures

The long-term guarantee measures are quite technical and form a playground for actuaries. The matching adjustment and the volatility adjustment should result in less volatile own funds, while the transitional measures provide for a gradual phasing-in to the S2 regime. But applying these measures has an impact that is much wider than one might assume when looking at the measures as such. Therefore, not only actuaries should concern themselves with these measures. As an initial orientation we have summarised the consequences of using the long-term guarantee measures.

  • When using the matching adjustment, the volatility adjustment or either of the transitional measures:

    • the insurer must perform the assessment of compliance with the capital requirements as part of the ORSA with and without taking that measure into account
    • a supervisory authority may set a capital add-on if it concludes that the risk profile of the insurer deviates significantly from the assumptions underlying the relevant measure
    • the insurer must disclose in the report on solvency and financial condition that the insurer applies the measure and what would be the impact of not applying it, and with respect to the matching adjustment further information requirements apply. It seems to follow from the draft Delegated Acts S2 that with respect to the other measures than the matching adjustment, insurers must also include a statement if they do not use the measure (which for the volatility adjustment also follows from O2).
  • When applying the matching adjustment or the volatility adjustment, the insurer must set up a liquidity plan projecting the incoming and outgoing cash flows in relation to the assets and liabilities subject to those adjustments. As part of its asset-liability management, the insurer must also regularly assess the impact of:

    • reducing the relevant adjustment to zero
    • the sensitivity of its technical provisions and own funds to the assumptions underlying the calculation of the relevant adjustment and the possible effect of a forced sale of assets on its own funds
    • with respect to the matching adjustment only, the sensitivity of the technical provisions and own funds to changes in the composition of the assigned assets.
  • It follows from the draft Delegated Acts S2 that when applying the matching adjustment a different calculation for the spread risk sub-module of the solvency capital requirement applies and the own funds are reduced by the amount with which they exceed the solvency capital requirement associated with the matching adjustment portfolio (the relevant obligations and assigned assets).

An insurer must also regularly assess the sensitivity of its technical provisions and own funds to the assumptions underlying the extrapolation of the relevant risk-free interest rate term structure.


The question whether a third country's solvency regime is equivalent to the regime under S2 is relevant in three areas.

  • Reinsurance activities

    What is tested is whether the solvency regime of a third country that applies to reinsurance activities of undertakings from that country is equivalent to the solvency regime under S2. If the outcome is positive, reinsurance contracts entered into with undertakings from that third country will be treated under S2 as reinsurance contracts entered into with EEA insurers. Most importantly, an insurer will be able to take the capital relief into account that follows from reinsurance contracts meeting certain requirements.
  • Group solvency calculation

    What is tested is whether a third country insurer held by an EEA insurer is made subject to authorisation and is subject to a third country solvency regime equivalent to the solvency regime under S2. If the outcome is positive, when calculating the group solvency on the basis of the deduction and aggregation method, member states may provide that the EEA insurer can take into account the solvency capital requirement and own funds of the third country insurer based on the third country calculation, rather than making a new calculation on the basis of S2.
  • Group supervision

    What is tested is whether the third country group supervision of the third country where the parent company of the insurance group has its head office, is equivalent to the group supervision under S2. If the outcome is positive, member states must rely on the equivalent group supervision exercised by the third country supervisory authority, rather than applying S2 group supervision to the group as a whole.

The outcome of these tests is relevant for any internationally active insurer or insurance group. Each will have to assess the impact of third country equivalence on their reinsurance business, group solvency calculation and group supervision. The new elements brought by O2, which we discuss below, are important for this assessment as they widen the possible scope of third country equivalence.

As provided by S2, the Commission has set out in its draft Delegated Acts S2 the criteria to be met by a third country to be considered equivalent. A different set of strict criteria applies to each area. It has become apparent that not many third countries will fulfil these criteria. Only Bermuda and Switzerland are on track to obtain this status. This is why O2 introduces two new forms of equivalence:

  • temporary equivalence
  • provisional equivalence.

The temporary equivalence regime is available with respect to reinsurance activities and group supervision. Provisional equivalence is introduced with respect to the group solvency calculation.

Temporary equivalence

Temporary equivalence is awarded until 31 December 2020 (five years), with the possibility of extension for one year. When a third country's regime is considered temporarily equivalent, the same benefits apply as with respect to fully equivalent countries. With respect to group supervision, an exception applies if there is an EEA insurer within the group that has a balance sheet total that exceeds the balance sheet total of its third country parent.

Obviously, the conditions for temporary equivalence as set out in O2 are lighter than those for full equivalence. These conditions may still be further specified by the Commission in the Delegated Acts S2, but this is not yet included in the draft dated 14 March 2014. The most important condition is that the third country must give a commitment to adopt and apply a prudential regime that is capable of being assessed as equivalent and to engage in an equivalence assessment process in the future. The third country must have a work programme in place and allocate sufficient resources to fulfil its commitment. The current prudential regime must be risk based and establish "quantitative and qualitative solvency requirements and requirements relating to supervisory reporting and transparency and to the supervision of groups". The third country must also have an independent system of supervision.

Provisional equivalence

Provisional equivalence is granted for ten years and may be renewed indefinitely with additional periods of ten years. When a third country's regime is considered provisionally equivalent, the same benefits apply as with respect to fully equivalent countries.

The conditions for provisional equivalence are set out in O2. The Commission does not have the possibility to further detail these conditions in the Delegated Acts S2. The most important difference from the temporary regime is that the third country does not have to commit to adopt a regime that is capable of being assessed as equivalent to the S2 regime. It is sufficient that it can be shown, not necessarily by the third country, that the current system would be able to meet the full equivalence requirements, or that that regime may be adopted in the future. No time limit is set for this adoption in the future.

This outcome is good news for insurers with a subsidiary in a third country. If that third country is considered to have a prudential regime in place that is provisionally equivalent, the insurer is able to use the third country calculations for the required and available capital of the subsidiary for at least ten years and probably for additional periods of ten years. This diminishes the risk that an insurance group must hold further own funds for its third country subsidiary than follows from the rules of that third country. As set out above, this outcome only applies if the group solvency is calculated on the basis of the deduction and aggregation method.


O2 contains a number of transitional measures. The transitional measures with respect to the risk-free interest rate structure and the technical provisions were already discussed above (see 2. Long-term guarantee package, sub-section Transitional measures). Other examples of transitional measures included in O2 are those relating to

  • own funds
  • non-compliance with the solvency capital requirement
  • supervisory reporting
  • disclosure requirements
  • the calculation of the solvency capital requirement using the standard formula (regarding the parameters to be used when calculating the concentration risk sub-module, the spread risk sub-module, or the equity risk sub-module)
  • tradable securities or other financial instruments based on repackaged loans issued before 1 January 2011.

Own funds

With respect to own funds, the transitional measures provide for a grandfathering regime with respect to capital instruments issued under current law.

Tier 1

Capital items that were issued prior to 1 January 2016 (or prior to the date that the Delegated Acts S2 come into force, if earlier) and that under current law can be used to meet the available solvency margin up to 50% of the solvency margin will be included in Tier 1 basic own funds for up to ten years after 1 January 2016. The wording suggests that capital items that meet the S2 requirements to directly classify as Tier 1 or Tier 2 own funds, cannot rely on this transitional measure. This seems to mean that in theory an insurer could end up with own funds with a lower classification than they could have had (Tier 1), simply because they meet the S2 requirements to qualify as Tier 2 own funds. Whether this will pose a problem in practice remains to be seen.

Tier 2

Capital items that were issued prior to the cut-off date and that under current law can be used to meet the available solvency margin up to 25% of the solvency margin will be included in Tier 2 basic own funds for up to ten years after 1 January 2016.

This grandfathering regime may lead to the conclusion that up to 1 January 2016 insurers can continue to issue capital instruments without taking the S2 requirements into account. However, as it has become market practice to take these new requirements into account, we believe it unlikely that the Dutch Central Bank would find that acceptable. In any case, insurers should carefully assess the classification of their current capital items under S2.

Non-compliance with the solvency capital requirement

The transitional measures provide a grace period for insurers that meet the solvency rules on 31 December 2015, but do not comply with the S2 solvency capital requirement on 1 January 2016. In that case the relevant supervisory authority must require that the insurer take the necessary measures to ensure compliance by 31 December 2017.


The S2 rules, as amended by O2, that bring about novelties must be transposed in national law by 31 March 2015. They, and the rest of S2, must apply as from 1 January 2016. The only exception to this rule is that the S2 phasing-in provision, introduced by O2, must already apply from 1 April 2015.

The phasing-in provision requires that supervisory authorities have certain powers prior to the entry into force of the national S2 implementation acts. This ensures that certain steps for the preparation of S2 can already be set prior to its application date. For instance, from 1 April 2015 supervisory authorities must have the power to decide on the approval of a full or partial internal model and on ancillary own funds. As of the same date the supervisory authorities should have the power to identify the group supervisor and to establish a college of supervisors. From 1 July 2015, supervisory authorities must have the power to, for instance, make a determination of third country equivalence and determine the application of transitional measures.

Insurers now know for certain as from what date they may expect decisions from their supervisory authorities on certain important topics, such as the approval of their internal model.


We highlight a few other changes brought about by O2.

  • O2 introduces specific rules on when a supervisory authority may limit regular supervisory reporting with a frequency shorter than one year.
  • O2 increases the floor of the minimum capital requirement.
  • O2 obligates member states to require insurers to disclose publicly "at the level of the group, on an annual basis, the legal structure and the governance and organisational structure, including a description of all subsidiaries, material related undertakings and significant branches belonging to the group".
  • O2 introduces the European Cooperative Society as a newly allowed legal form for insurers. This form may only be used to the extent that the member state concerned allows for the legal form of a cooperative society to take up the business of life insurance, which is not the case in the Netherlands.
  • O2 requires the European Commission to review by 31 December 2020 the appropriateness of the methods, assumptions and standard parameters used when calculating the solvency capital requirement standard formula.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Some comments from our readers…
“The articles are extremely timely and highly applicable”
“I often find critical information not available elsewhere”
“As in-house counsel, Mondaq’s service is of great value”

Related Topics
Related Articles
Up-coming Events Search
Font Size:
Mondaq on Twitter
Mondaq Free Registration
Gain access to Mondaq global archive of over 375,000 articles covering 200 countries with a personalised News Alert and automatic login on this device.
Mondaq News Alert (some suggested topics and region)
Select Topics
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of

To Use you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions